A hand-held EEG device approved in 2016 by the US Food and Drug Administration that is commercially available can quickly and with 97 percent accuracy rule out whether a person with a head injury likely has brain bleeding and needs further evaluation and treatment. These trial results also show the device predicted the absence of potentially dangerous brain bleeding 52 percent of the time in the participants tested.